These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6446265)

  • 1. Antigenic competition as a therapeutic concept for alopecia areata.
    Happle R
    Arch Dermatol Res; 1980; 267(1):109-14. PubMed ID: 6446265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNCB therapy of alopecia areata].
    Happle R
    Z Hautkr; 1979 May; 54(10):426-9. PubMed ID: 314203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinitrochlorobenzene therapy for alopecia areata.
    Happle R; Cebulla K; Echternacht-Happle K
    Arch Dermatol; 1978 Nov; 114(11):1629-31. PubMed ID: 152611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of alopecia areata with dinitrochlorobenzene.
    Daman LA; Rosenberg EW; Drake L
    Arch Dermatol; 1978 Jul; 114(7):1036-8. PubMed ID: 308348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.
    Happle R; Klein HM; Macher E
    Arch Dermatol Res; 1986; 278(3):214-8. PubMed ID: 2873796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cell decrease in alopecia areata.
    Ledesma GN; York KK
    Arch Dermatol Res; 1982; 274(1-2):1-8. PubMed ID: 6219633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].
    Freyschmidt-Paul P; Happle R; Hoffmann R
    Hautarzt; 2003 Aug; 54(8):713-22. PubMed ID: 12942185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity: alopecia areata.
    Hordinsky M; Ericson M
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):73-8. PubMed ID: 14870990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiological studies on the alopecic (DEBR) rat.
    Michie HJ; Jahoda CA; Oliver RF; Poulton TA
    Br J Dermatol; 1990 Nov; 123(5):557-67. PubMed ID: 2147388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of alopecia areata.
    Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
    Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.